| A pathophysiological framework of hippocampal dysfunction in ageing and disease SA Small, SA Schobel, RB Buxton, MP Witter, CA Barnes Nature Reviews Neuroscience 12 (10), 585-601, 2011 | 1023 | 2011 |
| Maternal immune activation and abnormal brain development across CNS disorders I Knuesel, L Chicha, M Britschgi, SA Schobel, M Bodmer, JA Hellings, ... Nature Reviews Neurology 10 (11), 643-660, 2014 | 929 | 2014 |
| Targeting huntingtin expression in patients with Huntington’s disease SJ Tabrizi, BR Leavitt, GB Landwehrmeyer, EJ Wild, C Saft, RA Barker, ... New England Journal of Medicine 380 (24), 2307-2316, 2019 | 724 | 2019 |
| Imaging patients with psychosis and a mouse model establishes a spreading pattern of hippocampal dysfunction and implicates glutamate as a driver SA Schobel, NH Chaudhury, UA Khan, B Paniagua, MA Styner, I Asllani, ... Neuron 78 (1), 81-93, 2013 | 555 | 2013 |
| Differential targeting of the CA1 subfield of the hippocampal formation by schizophrenia and related psychotic disorders SA Schobel, NM Lewandowski, CM Corcoran, H Moore, T Brown, ... Archives of general psychiatry 66 (9), 938-946, 2009 | 422 | 2009 |
| Hippocampal dysfunction in the pathophysiology of schizophrenia: a selective review and hypothesis for early detection and intervention JA Lieberman, RR Girgis, G Brucato, H Moore, F Provenzano, L Kegeles, ... Molecular psychiatry 23 (8), 1764-1772, 2018 | 374 | 2018 |
| Type III neuregulin-1 is required for normal sensorimotor gating, memory-related behaviors, and corticostriatal circuit components YJJ Chen, MA Johnson, MD Lieberman, RE Goodchild, S Schobel, ... Journal of Neuroscience 28 (27), 6872-6883, 2008 | 213 | 2008 |
| The relationship of social function to depressive and negative symptoms in individuals at clinical high risk for psychosis CM Corcoran, D Kimhy, MA Parrilla-Escobar, VL Cressman, AD Stanford, ... Psychological medicine 41 (2), 251-261, 2011 | 196 | 2011 |
| A biological classification of Huntington's disease: the Integrated Staging System SJ Tabrizi, S Schobel, EC Gantman, A Mansbach, B Borowsky, ... The Lancet Neurology 21 (7), 632-644, 2022 | 175 | 2022 |
| Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington’s disease LM Byrne, FB Rodrigues, EB Johnson, PA Wijeratne, E De Vita, ... Science translational medicine 10 (458), eaat7108, 2018 | 172 | 2018 |
| Duration of illness and treatment effects on hippocampal volume in male patients with schizophrenia MH Chakos, SA Schobel, H Gu, G Gerig, D Bradford, C Charles, ... The British Journal of Psychiatry 186 (1), 26-31, 2005 | 172 | 2005 |
| Childhood trauma and prodromal symptoms among individuals at clinical high risk for psychosis JL Thompson, M Kelly, D Kimhy, JM Harkavy-Friedman, S Khan, ... Schizophrenia research 108 (1-3), 176-181, 2009 | 162 | 2009 |
| Cerebral blood flow predicts differential neurotransmitter activity J Dukart, Š Holiga, C Chatham, P Hawkins, A Forsyth, R McMillan, ... Scientific reports 8 (1), 4074, 2018 | 145 | 2018 |
| Temporal association of stress sensitivity and symptoms in individuals at clinical high risk for psychosis JE Devylder, S Ben-David, SA Schobel, D Kimhy, D Malaspina, ... Psychological medicine 43 (2), 259-268, 2013 | 134 | 2013 |
| Motor, cognitive, and functional declines contribute to a single progressive factor in early HD SA Schobel, G Palermo, P Auinger, JD Long, S Ma, OS Khwaja, ... Neurology 89 (24), 2495-2502, 2017 | 133 | 2017 |
| Anterior hippocampal and orbitofrontal cortical structural brain abnormalities in association with cognitive deficits in schizophrenia SA Schobel, MA Kelly, CM Corcoran, K Van Heertum, R Seckinger, ... Schizophrenia research 114 (1-3), 110-118, 2009 | 127 | 2009 |
| Temporal association of cannabis use with symptoms in individuals at clinical high risk for psychosis CM Corcoran, D Kimhy, A Stanford, S Khan, J Walsh, J Thompson, ... Schizophrenia research 106 (2-3), 286-293, 2008 | 112 | 2008 |
| Interneuron precursor transplants in adult hippocampus reverse psychosis-relevant features in a mouse model of hippocampal disinhibition AI Gilani, MO Chohan, M Inan, SA Schobel, NH Chaudhury, S Paskewitz, ... Proceedings of the National Academy of Sciences 111 (20), 7450-7455, 2014 | 90 | 2014 |
| Mutant huntingtin and neurofilament light have distinct longitudinal dynamics in Huntington’s disease FB Rodrigues, LM Byrne, R Tortelli, EB Johnson, PA Wijeratne, M Arridge, ... Science translational medicine 12 (574), eabc2888, 2020 | 89 | 2020 |
| Gantenerumab: an anti-amyloid monoclonal antibody with potential disease-modifying effects in early Alzheimer’s disease RJ Bateman, J Cummings, S Schobel, S Salloway, B Vellas, M Boada, ... Alzheimer's research & therapy 14 (1), 178, 2022 | 79 | 2022 |
